Appointment of Independent Non-Executive Director

RNS Number : 7405M
Empresaria Group PLC
16 January 2023
 

16 January 2023

 

Empresaria Group plc

("Empresaria" or the "Company")

 

Appointment of Independent Non-Executive Director

Empresaria, the global specialist staffing group, is pleased to announce the appointment of Steve Bellamy to the Board as an Independent Non-Executive Director, with immediate effect. Steve will join the Audit, Remuneration and Nomination Committees immediately on appointment and Penny Freer will stand down from the Audit Committee.

Steve is a Chartered Accountant with extensive experience as a chair and non-executive director with a wide range of both public and private companies. He is currently the Senior Independent Director at Caffyns PLC and prior recent appointments include Non-Executive Director of Advanced Medical Solutions Group plc and Michelmersh Brick Holdings plc, and Chairman of Becrypt Limited and Concirrus Limited. Steve was also formerly Chief Operating Officer and Finance Director of Sherwood International plc.

Further to the Company's announcement on 6 June 2022, the process is ongoing to appoint an additional independent Non-Executive Director and a further announcement will be made in due course.

 

Penny Freer, Interim Chair, commented:

"I am delighted to welcome Steve to the Empresaria Board. He has extensive experience of working with ambitious growth companies, as well as a strong focus on strategic planning and execution. His skill set will both complement and further strengthen our Board as we continue to execute our strategy."

 

Following these changes, the composition of the Board Committee membership is as follows:

Audit Committee

Remuneration Committee

Nominations Committee

Zach Miles (Chair)

Steve Bellamy

Zach Miles (Chair)

Penny Freer

Steve Bellamy

Penny Freer (Chair)

Zach Miles

Steve Bellamy

Other than as disclosed below, there are no further disclosures to be made in connection with Stephen Gerard Bellamy, aged 63, in accordance with AIM Rule 17 and paragraph (g) of Schedule Two of the AIM Rules for Companies:

Current directorships

Past directorships (last five years)

Caffyns PLC

Advanced Medical Solutions Group plc

Becrypt Limited 

Accretion Capital LLP 

Michelmersh Brick Holdings plc 

Concirrus Limited

 

- Ends -

 

Enquiries:

Empresaria Group plc
Rhona Driggs, Chief Executive Officer
Tim Anderson, Chief Financial Officer

via Alma PR

Singer Capital Markets (Nominated Adviser and Joint Broker)
Shaun Dobson / James Moat

020 7496 3000

Cenkos Securities plc (Joint Broker)
Katy Birkin / Charlie Combe (Corporate Finance)
Michael Johnson / Jasper Berry (Sales)

020 7397 3900

Alma PR (Financial PR)
Sam Modlin
Hilary Buchanan

Pippa Crabtree

020 3405 0205
empresaria@almapr.com

Notes for editors:

§   Empresaria Group plc is a global specialist staffing group.  We are driven by our purpose to positively impact the lives of people, while delivering exceptional talent to our clients globally.  We offer temporary and contract recruitment, permanent recruitment and offshore services across six sectors: Professional, IT, Healthcare, Property, Construction & Engineering, Commercial and Offshore Services.

  §   Empresaria is structured in four regions (UK & Europe, APAC, Americas and Offshore Services) and operates from locations across the world including the four largest staffing markets of the US, Japan, UK and Germany along with a strong presence elsewhere in Asia Pacific and Latin America.

  §   Empresaria is listed on AIM under ticker EMR.  For more information visit www.empresaria.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAXFDFLLDEFA
UK 100